本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

66.17
-1.3400-1.98%
盤後66.170.00000.00%19:30 EDT
成交量:114.98萬
成交額:7,694.43萬
市值:62.37億
市盈率:-138.88
高:68.73
開:67.76
低:66.11
收:67.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.91
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:254.35
市盈率(LYR):-231.08

資料載入中...

2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities